(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

GUBRA

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: Estados Unidos

Snapshot rápido

GUBRA

ST13

US500000079246634

Classe

5, 9, 10, 35, 42, 44

Pedido

79246634

Registro

5958193

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

46

Atualização mais recente

14/07/2026

Tipo de marca

Verbal

Classes Nice

5, 9, 10, 35, 42, 44

Data de depósito

20/09/2018

Data de registro

14/01/2020

Data de expiração

-

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

14/01/2020

Última transação

14/07/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

16

Localização do titular

DK

Examinador

GOODWIN, KATRINA JOYE

Unidade examinadora

O30

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

G. A. (pessoa física)

Representantes

Meichelle R. MacGregor Cowan, Liebowitz & Latman, P.C.

Classificação técnica

Classes Nice

Classe 5Classe 9Classe 10Classe 35Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceutical and veterinary preparations for the prevention of metabolicinflammatoryfibroticcentral nervous systemcardiovascularrenalhepaticgastrointestinalcancerimmune-system disorders; sanitary preparations for medical purposes; neuro-pharmaceutical preparations in the nature of pharmaceutical preparations for the treatment of metabolicinflammatoryfibroticcentral nervous systemcardiovascularrenalhepaticgastrointestinalcancerimmune-system disorders; preparations for treating neurological disorders; chemicals preparations for medical purposesfor metabolicinflammatoryfibroticcentral nervous systemcardiovascularrenalhepaticgastrointestinalcancerimmune-system disorders; chemicals used in the treatment of neurological disorders

Classe 9

Scientificnauticalsurveying photographiccinematographicopticalweighingmeasuring signalingcheckinglife-saving and teaching apparatus and instrumentsanimal monitoring and measurement and devices for laboratory testing; apparatus and instruments for conductingswitchingtransformingaccumulatingregulating or controlling electricity in the nature of electrical controlling devices; apparatus for recordingtransmission or reproduction of sound or images; blank magnetic data carriers; blank record disks; blank compact discs; compact discs featuring music; blank recordable DVDs; digital recording mediapre-recorded video cassettesdigital video discsdigital versatile discsdownloadable audio and video recordings featuring business specific information and data as well as scientific technologies and methodologies; mechanisms for coin-operated apparatus; cash registers; calculating machines; data processing equipment; computers; Computer software for use in medical and laboratory decision support systems in the field of metabolicinflammatoryfibroticcentral nervous systemcardiovascularrenalhepaticgastrointestinalcancerimmune-system disorders

Classe 10

Surgical apparatus and instruments for medicaldental and veterinary use; artificial limbseyes and teeth; orthopedic articlesorthopedic apparatus and instruments for medicaldental and veterinary surgical procedures; suture materials

Classe 35

Advertising; business management; business administration; Office functionsmedical data management in the form of data entry or data collection

Classe 42

Scientific and industrial research in the field of metabolicinflammatoryfibroticcentral nervous systemcardiovascularrenalhepaticgastrointestinalcancerimmune-system disorders and data managementplanningprocessinganalysis and presentation software relating to veterinarymedicaldental industries; pharmaceutical research; neuropharmaceutical research; research into the treatment of illnesses affecting the central nervous system

Classe 44

Medical services; veterinary services; hygienic and beauty care for human beings and animals; medical servicesmedical data analysis

Publicações

Histórico de despachos e eventos da marca no USPTO.

46 publicações encontradas

ES75

TEAS SECTION 71 & 15 RECEIVED

14/07/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

12/02/2026

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

14/01/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

13/08/2021

NREP

NEW REPRESENTATIVE AT IB RECEIVED

18/09/2020

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

15/05/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

29/04/2020

FIMP

FINAL DISPOSITION PROCESSED

29/04/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

14/04/2020

LIMN

LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED

28/02/2020

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

14/02/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

14/01/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

29/10/2019

PUBO

PUBLISHED FOR OPPOSITION

29/10/2019

GPNX

NOTIFICATION PROCESSED BY IB

25/10/2019

CORN

CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED

18/10/2019

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

09/10/2019

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

09/10/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/10/2019

RFNT

REFUSAL PROCESSED BY IB

05/10/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

23/09/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/09/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/09/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/09/2019

CNRT

NON-FINAL ACTION MAILED

21/08/2019

CNRT

NON-FINAL ACTION WRITTEN

20/08/2019

CNEA

EXAMINERS AMENDMENT MAILED

19/08/2019

XAEC

EXAMINER'S AMENDMENT ENTERED

16/08/2019

CNEA

EXAMINERS AMENDMENT -WRITTEN

16/08/2019

RINX

USPTO CORRECTION PROCESSED BY IB

09/08/2019

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

09/08/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

23/07/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

23/07/2019

ALIE

ASSIGNED TO LIE

22/07/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

17/07/2019

CRSN

CORRECTION SENT TO IB

23/04/2019

CRCR

CORRECTION CREATED FOR IB

23/04/2019

RFNT

REFUSAL PROCESSED BY IB

02/02/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

17/01/2019

RFRR

REFUSAL PROCESSED BY MPU

17/01/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

06/01/2019

CNRT

NON-FINAL ACTION WRITTEN

05/01/2019

DOCK

ASSIGNED TO EXAMINER

02/01/2019

MAFR

APPLICATION FILING RECEIPT MAILED

04/12/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

30/11/2018

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

29/11/2018

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace GUBRA ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.